Abstract
Cibacron blue F3GA (CB) was found to reduce the MIC of oxacillin for methicillin-resistant Staphylococcus aureus (MRSA). This effect was not observed with methicillin-susceptible S. aureus. CB alters the resistance level of MRSA through a factor(s) other than mecA-related products, major autolysins, or femAB products. The exact target(s) of CB in causing the effect is unknown.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Drug Interactions
-
Drug Resistance, Multiple
-
Methicillin Resistance / physiology
-
Microbial Sensitivity Tests
-
Oxacillin / pharmacology
-
Penicillins / pharmacology
-
Protein Synthesis Inhibitors / pharmacology*
-
Staphylococcus aureus / drug effects*
-
Triazines / pharmacology*
Substances
-
Penicillins
-
Protein Synthesis Inhibitors
-
Triazines
-
Cibacron Blue F 3GA
-
Oxacillin